These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8290432)

  • 1. A pharmacokinetic interaction between cimetidine or ranitidine and lornoxicam.
    Ravic M; Salas-Herrera I; Johnston A; Turner P; Foley K; Rosenow DE
    Postgrad Med J; 1993 Nov; 69(817):865-6. PubMed ID: 8290432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neither cimetidine nor probenecid affect the pharmacokinetics of tenoxicam in normal volunteers.
    Day RO; Geisslinger G; Paull P; Williams KM
    Br J Clin Pharmacol; 1994 Jan; 37(1):79-81. PubMed ID: 8148224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interactions between NSAIDs (indomethacin or sulindac) and H2-receptor antagonists (cimetidine or ranitidine) in human volunteers.
    Delhotal-Landes B; Flouvat B; Liote F; Abel L; Meyer P; Vinceneux P; Carbon C
    Clin Pharmacol Ther; 1988 Oct; 44(4):442-52. PubMed ID: 2901930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of lornoxicam in man.
    Hitzenberger G; Radhofer-Welte S; Takacs F; Rosenow D
    Postgrad Med J; 1990; 66 Suppl 4():S22-7. PubMed ID: 2284217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of pharmacokinetic drug/drug interactions from In vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants.
    Kohl C; Steinkellner M
    Drug Metab Dispos; 2000 Feb; 28(2):161-8. PubMed ID: 10640513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple dose pharmacokinetics and acute safety of piroxicam and cimetidine in the cat.
    Heeb HL; Chun R; Koch DE; Moore L; Radlinsky M; Corse M; Pellerin MA; Garrett L; Hunter RP
    J Vet Pharmacol Ther; 2005 Oct; 28(5):447-52. PubMed ID: 16207307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of lornoxicam. A short half-life oxicam.
    Skjodt NM; Davies NM
    Clin Pharmacokinet; 1998 Jun; 34(6):421-8. PubMed ID: 9646006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetic studies with lornoxicam.
    Turner P; Johnston A
    Postgrad Med J; 1990; 66 Suppl 4():S28-9. PubMed ID: 2284218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lack of pharmacokinetic interaction between ranitidine and piroxicam.
    Dixon JS; Lacey LF; Pickup ME; Langley SJ; Page MC
    Eur J Clin Pharmacol; 1990; 39(6):583-6. PubMed ID: 1982764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype.
    Zhang Y; Zhong D; Si D; Guo Y; Chen X; Zhou H
    Br J Clin Pharmacol; 2005 Jan; 59(1):14-7. PubMed ID: 15606435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
    Olkkola KT; Brunetto AV; Mattila MJ
    Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of oxaprozin with acetaminophen, cimetidine, and ranitidine.
    Scavone JM; Greenblatt DJ; Matlis R; Harmatz JS
    Eur J Clin Pharmacol; 1986; 31(3):371-4. PubMed ID: 3792438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of lornoxicam in human plasma by LC/MS/MS].
    Zeng YL; Chen XY; Zhang YF; Zhong DF
    Yao Xue Xue Bao; 2004 Feb; 39(2):132-5. PubMed ID: 15127622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of lornoxicam co-administration on phenprocoumon pharmacokinetics and pharmacodynamics.
    Masche UP; Rentsch KM; von Felten A; Meier PJ; Fattinger KE
    Eur J Clin Pharmacol; 1999 Jan; 54(11):857-64. PubMed ID: 10027661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption of oral lornoxicam in healthy volunteers using a granular formulation in comparison with standard tablets.
    Bareggi SR; Gambaro V; Valenti M; Benvenuti C
    Arzneimittelforschung; 1997 Jun; 47(6):755-7. PubMed ID: 9239455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of the anti-ulcer medications ranitidine, cimetidine, and omeprazole following administration of multiple doses to exercised Thoroughbred horses.
    Knych HK; Stanley SD; Arthur RM; McKemie DS
    J Vet Pharmacol Ther; 2017 Jan; 40(1):92-96. PubMed ID: 27292271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacological studies of some possible interactions of lornoxicam with other drugs.
    Ravic M; Johnston A; Turner P
    Postgrad Med J; 1990; 66 Suppl 4():S30-4. PubMed ID: 2126624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human drug absorption kinetics and comparison to Caco-2 monolayer permeabilities.
    Polli JE; Ginski MJ
    Pharm Res; 1998 Jan; 15(1):47-52. PubMed ID: 9487545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications and simulations of a discontinuous oral absorption pharmacokinetic model.
    Witcher JW; Boudinot FD
    Pharm Res; 1996 Nov; 13(11):1720-4. PubMed ID: 8956341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the CYP2C9*3 allele on lornoxicam metabolism.
    Liu YL; Zhang W; Tan ZR; Ouyang DS; Luo CH; Liu ZQ; Qiu Y; Chen Y; He YJ; Zhou G; Zhou HH
    Clin Chim Acta; 2006 Feb; 364(1-2):287-91. PubMed ID: 16182270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.